Ident. | Authors (with country if any) | Title |
---|
000608 |
Elvira De Leonibus [Italie] ; Francesca Manago [Italie] ; Francesco Giordani [Italie] ; Francesco Petrosino [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease |
000800 |
Gabor Szenasi [Hongrie] ; Miklos Vegh [Hongrie] ; Geza Szabo [Hongrie] ; Szabolcs Kertesz [Hongrie] ; Gabor Kapus [Hongrie] ; Mihaly Albert [Hongrie] ; Zoltan Greff [Hongrie] ; Istvan Ling [Hongrie] ; Jozsef Barkoczy [Hongrie] ; Gyula Simig [Hongrie] ; Michael Spedding [France] ; Laszlo G. Jr Harsing [Hongrie] | 2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects |
000875 |
Heike Wulff [États-Unis] ; Aaron Kolski-Andreaco [États-Unis] ; Ananthakrishnan Sankaranarayanan [États-Unis] ; Jean-Marc Sabatier [France] ; Vikram Shakkottai [États-Unis] | Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications |
000982 |
Rosa Planells-Cases [Espagne] ; Juan Lerma [Espagne] ; Antonio Ferrer-Montiel [Espagne] | Pharmacological intervention at ionotropic glutamate receptor complexes |
000B24 |
Nathalie Turle-Lorenzo [France] ; Nathalie Breysse [France] ; Christelle Baunez [France] ; Marianne Amalric [France] | Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease |
000C11 |
Roberto Coccurello [France] ; Nathalie Breysse [France] ; Marianne Amalric [France] | Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats |
000D82 |
S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France] | Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death |
000E30 |
Anne-Marie Bonnet [France] | Récepteurs α2-adrénergiques et maladie de Parkinson |
000E94 |
T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France] | Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat |
000F82 |
| EFFETS D'UNE DEPOLARISATION CHRONIQUE SUR LE DEVELOPPEMENT ET LA SURVIE DES NEURONES DOPAMINERGIQUES DU MESENCEPHALE : MODULATION PAR DES ANTAGONISTES DE LA TRANSMISSION GLUTAMATERGIQUE |
001064 |
O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
001172 |
L. A. Smith [Royaume-Uni] ; M. G. Jackson [Royaume-Uni] ; C. Bonhomme [France] ; C. Chezaubernard [France] ; K. B. Pearce [Royaume-Uni] ; P. Jenner [Royaume-Uni] | Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset |
001176 |
O. Rascol [France] | The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease |
001190 |
Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
001321 |
W. Koek [France] | N-methyl-D-aspartate antagonists and drug discrimination |
001345 |
E. Bezard [France] ; C. Brefel [France] ; F. Tison [France] ; H. Peyro-Saint-Paul [France] ; P. Ladure [France] ; O. Rascol [France] ; C. E. Gross [France] | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in mptp-treated monkey |
001377 |
| Synthèse de radioligands marqués au brome-76 et au carbone-11 pour l'étude des récepteurs N-Méthyl-D-Aspartate par Tomographie d'Emission de Positons |
001403 |
J. M. Senard [France] ; J. L. Montastruc [France] | Approche pharmacologique des dysautonomies |
001407 |
C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
001433 |
E. X. Albuquerque [États-Unis, Brésil] ; E. F. R. Pereira [États-Unis] ; M. F. M. Braga [États-Unis, Brésil] ; H. Matsubayashi [États-Unis] ; M. Alkondon [États-Unis] | Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine |
001576 |
J. L. Montastruc [France] ; O. Rascol [France] ; J. M. Senard [France] | Glutamate antagonists and Parkinson's disease : A review of clinical data |
001618 |
P. Morel [France] | Les perspectives thérapeutiques de la maladie de Parkinson |
001649 |
A. F. Carpentier [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] | Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease |
001660 |
M. Spedding [France] ; M. Williams [États-Unis] | Developments in purine and pyridimidine receptor-based therapeutics |
001737 |
B. Lannes [France] ; V. Bernard [France] ; B. Bloch [France] ; G. Micheletti [France] | Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene |
001786 |
A. Boireau [France] ; J.-M. Miquet ; P. Dubedat ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo |
001792 |
O. Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
001A98 |
E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
001B80 |
P. Hantraye ; B. Maziere ; M. Maziere ; H. Fukuda ; R. Naquet | Dopaminergic and benzodiazepine receptors studied in vivo by PET |